Digital Library
Close Browse articles from a journal
 
Search for with title:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             394 results found
no title author magazine year volume issue page(s) type
1 Acceptance of third-party cardiac allografts in neonatally-tolerized mice is transferable by regulatory CD4+ T cells Hofmann, B
 2004
 23 2S p. S133-
1 p.
 article
2 A controlled trial of exercise rehabilitation after lung transplantation Tegtbur, U
 2004
 23 2S p. S95-
1 p.
 article
3 A cost-effectiveness and cost-utility study of lung transplantation Vasiliadis, H.M
 2004
 23 2S p. S132-
1 p.
 article
4 Acute cellular rejection after human heart transplantation is associated with ICOS+ graft-infiltrating T lymphocytes and increased endothelial expression of inducible costimulator ligand (ICOSL) Klingenberg, R
 2004
 23 2S p. S123-
1 p.
 article
5 Adenoviral overexpression of human BCL-2 in donor rodent lung allografts reduces ischemia/reperfusion injury and improves post-transplant lung function Cooke, D.T
 2004
 23 2S p. S100-S101
2 p.
 article
6 A donor history of smoking affects early but not late outcome from lung transplantation (LTX): a 7-year single centre experience Oto, T
 2004
 23 2S p. S96-
1 p.
 article
7 A heat shock protein 70 inducer, geranylgeranylacetone, suppresses ischemia-reperfusion injury after lung transplantation in rats Sugawara, T
 2004
 23 2S p. S152-
1 p.
 article
8 Airway complications following pediatric lung transplantation: incidence, etiology, management and outcome Choong, C.K
 2004
 23 2S p. S59-
1 p.
 article
9 Alteration in b-type natriuretic peptide levels with epoprostenol therapy in pulmonary hypertension: an important marker of clinical outcome Park, M.H
 2004
 23 2S p. S55-
1 p.
 article
10 Alterations in gene expression of toll-like receptors in human lung transplantation Andrade, C.F
 2004
 23 2S p. S133-S134
2 p.
 article
11 A 12-month, multicenter, randomized, adaptive design, open-label study to evaluate the benefit of C2 hour monitoring of neoral on safety and efficacy outcomes in de novo cardiac transplant recipients receiving basiliximab induction Cantarovich, M
 2004
 23 2S p. S107-
1 p.
 article
12 Anaemia in lung transplant recipients. effect on health related quality of life Swarbrick, D
 2004
 23 2S p. S93-S94
2 p.
 article
13 An automatic speed adaptation system for implantable rotary blood pumps and its clinical evaluation Schima, H
 2004
 23 2S p. S108-
1 p.
 article
14 10 and 20-year long-term survival after pediatric orthotopic heart transplantation Kouretas, P
 2004
 23 2S p. S59-S60
2 p.
 article
15 Anemia in advanced chronic heart failure: the importance of iron deficiency Karageorgopoulos, D
 2004
 23 2S p. S83-
1 p.
 article
16 Antagonists of stretch-activated ion channels restore contractile function in hamster dilated cardiomyopathy Nicolosi, A.C
 2004
 23 2S p. S173-
1 p.
 article
17 Aortic valve insufficiency prior to LVAD reduces survival to transplant: the temple university experience Feller, E.D
 2004
 23 2S p. S104-
1 p.
 article
18 A prospective longitudinal study of airway vasculature in the pathogenesis of bronchioitis obliterans syndrome(BOS) Langenbach, S.Y
 2004
 23 2S p. S54-S55
2 p.
 article
19 A randomized clinical trial of tacrolimus [PROGRAF®] and cyclosporine [NEORAL®] immunosuprression in pediatric heart recipients Pollock-BarZiv, S.M
 2004
 23 2S p. S78-
1 p.
 article
20 A randomized evaluation of a telehealth intervention to improve well-being, mood states, and social intimacy in wait-listed lung transplant patients Rodrigue, J.R
 2004
 23 2S p. S135-
1 p.
 article
21 A randomized, prospective, multi-center comparison of tacrolimus, mycophenolate mofetil (MMF) and steroids vs. cyclosporine (modified usp), mmf and steroids vs tacrolimus, sirolimus and steroids in de novo cardiac transplant recipients - 6 month report Kobashigawa, J.A
 2004
 23 2S p. S106-
1 p.
 article
22 A randomized trial of early administration of inhaled cyclosporine in lung transplant recipients Iacono, A.T
 2004
 23 2S p. S175-
1 p.
 article
23 Are out hospital non heart beating donors (NHBD) better than brain death lung donors? Varela, A
 2004
 23 2S p. S87-
1 p.
 article
24 Association of anti-donor HLA class I antibodies with early coronary transplant vasculopathy Gonzalez-Stawinski, G.V
 2004
 23 2S p. S154-
1 p.
 article
25 Association of growth hormone therapy with the development of bronchiolitis obliterans syndrome in pediatric lung transplant recipients Sweet, S.C
 2004
 23 2S p. S127-
1 p.
 article
26 Autologous bone-marrow stem cell transplantation for ischaemic cardiomyopathy. first findings on procedure safety in human Angelini, A
 2004
 23 2S p. S85-
1 p.
 article
27 Basiliximab in critically ill children undergoing heart transplantation: initial data Ford, K.A
 2004
 23 2S p. S127-
1 p.
 article
28 Basiliximab in pediatric heart transplantation - initial experience Ward, K.M
 2004
 23 2S p. S77-
1 p.
 article
29 Bcl-xL gene transfer reduced apoptosis and preseved cardiac function after rat ischemia/reperfusion injury Morikawa, M
 2004
 23 2S p. S174-
1 p.
 article
30 Beneficial effects of tumor necrosis factor converting enzyme inhibitor on reimplantation lung injury Goto, T
 2004
 23 2S p. S150-S151
2 p.
 article
31 Benefits of three years of controlled exercise rehabilitation on heart transplant recipients Tegtbur, U
 2004
 23 2S p. S76-
1 p.
 article
32 Bile acids in bronchoalveolar lavage after lung transplantation as a marker of pulmonary aspiration associated with alveolar neutrophilia D’Ovidio, F
 2004
 23 2S p. S42-
1 p.
 article
33 Biochanin-a attenuates acute cardiac allograft rejection without affecting the reproductive system-in vivo and in vitro studies Schrepfer, S
 2004
 23 2S p. S134-
1 p.
 article
34 Body mass index and outcomes after left ventricular assist device placement Butler, J
 2004
 23 2S p. S104-
1 p.
 article
35 Bone morphogenetic protein (BMP) and SMAD signalling is important in the development of the human pulmonary vasculature Southwood, M.R
 2004
 23 2S p. S81-
1 p.
 article
36 Bone morphogenetic protein signalling is down regulated in the intima of transplant coronary artery vasculopathy lesions Southwood, M
 2004
 23 2S p. S80-S81
2 p.
 article
37 Both after heart and bone marrow transplantation the heart harvest bone marrow derived cardiomyocytes De Weger, R.A
 2004
 23 2S p. S161-S162
2 p.
 article
38 B-type natriuretic peptide, a marker for selection of heart transplant candidates Rothenburger, M
 2004
 23 2S p. S57-
1 p.
 article
39 Cardiac MR identifies transplantarteriopathy by a reduced endomyocardial perfusion Muehling, O.M
 2004
 23 2S p. S163-
1 p.
 article
40 Cardiopulmonary bypass, controlled reperfusion and C-1 esterase inhibitor prevent reperfusion injury in clinical lung transplantation Kamler, M
 2004
 23 2S p. S94-
1 p.
 article
41 Cardiothoracic transplantation for congenital heart disease in teenagers and adults Radley-Smith, R
 2004
 23 2S p. S55-S56
2 p.
 article
42 Caspofungin (CSF) for invasive aspergillosis after thoracic organ transplantation: first experience in 10 patients Groetzner, J
 2004
 23 2S p. S111-
1 p.
 article
43 Caveats of cyclosporine dosing based on C2 monitoring Thekkudan, J
 2004
 23 2S p. S139-
1 p.
 article
44 CCR5 blockade modulates the primate immune response after cardiac allotransplantation Schroeder, C
 2004
 23 2S p. S66-
1 p.
 article
45 CD20+ B-cells contribute to natural xenoreactive antibody production while elicited responses are partially mediated by CD19-/CD20-B-cells Gonzalez-Stawinski, G.V
 2004
 23 2S p. S86-S87
2 p.
 article
46 CD 154 blockade spares secondary immunity to influenza in primates Schroeder, C
 2004
 23 2S p. S137-S138
2 p.
 article
47 C4D staining of cardiac allografts correlates with alloantibody Smith, R.N
 2004
 23 2S p. S122-
1 p.
 article
48 Changes in collagen fractions of the myocardium induced by mechanical unloading of the left ventricle Mueller, J
 2004
 23 2S p. S105-
1 p.
 article
49 Chemokine MIG/CXCl9 stimulates CD4 T lymphocyte proliferation and IFN-γ expression Whiting, D
 2004
 23 2S p. S47-
1 p.
 article
50 Chemokinereceptor 7 (CCR7) plays an important role in the development of transplant arteriosclerosis Ensminger, S.M
 2004
 23 2S p. S159-
1 p.
 article
51 Chronic mechanical left ventricular support improves pulmonary vascular resistance in patients bridged to transplantation Kalya, A.V
 2004
 23 2S p. S83-
1 p.
 article
52 Chronic renal failure following lung transplantation Lake, K.D
 2004
 23 2S p. S68-
1 p.
 article
53 Circulating troponin I is a specific marker of donor heart dysfunction Nyawo, B
 2004
 23 2S p. S88-S89
2 p.
 article
54 Clinical application of a wear-resistant axial flow pump with an intelligent control algorithm as left ventricular assist devivce (LVAD) Mueller, J
 2004
 23 2S p. S148-
1 p.
 article
55 Clinton redux: it’s the malignancy, stupid! Hauptman, P.J
 2004
 23 2S p. S120-S121
2 p.
 article
56 CMV mismatch is not a risk factor for survival or severe bronchiolitis obliterans syndrome after lung transplantation Glanville, A.R
 2004
 23 2S p. S43-
1 p.
 article
57 Combination regimens of FK778 with tacrolimus and mycophenolate mofetil in experimental cardiac transplantation Deuse, T
 2004
 23 2S p. S138-
1 p.
 article
58 Combine autologous myoblast intramyocardial injection with coronary revascularization in patients with non-acute myocardial infarction Prosper, F
 2004
 23 2S p. S62-
1 p.
 article
59 Combined treatment with epsilon protein kinase C activator and delta protein kinase C inhibitor ameliorates ischemia reperfusion injury and graft coronary artery disease in murine cardiac allografts Tanaka, M
 2004
 23 2S p. S126-
1 p.
 article
60 Common chemokine receptor single nucleotide polymorphisms are associated with transplant vasculopathy in heart transplant recipients Miriuka, S.G
 2004
 23 2S p. S162-S163
2 p.
 article
61 Comparison and validation of three quality of life instruments for the functional assessment of pulmonary arterial hypertension Chua, R
 2004
 23 2S p. S143-
1 p.
 article
62 Comparison between gene expression in explanted hearts with endstage coronary artery disease and in “hibernating myocardium” Hausmann, H
 2004
 23 2S p. S56-
1 p.
 article
63 Comparison of basiliximab and antithymocyte globulin as induction agents after lung transplantation Hachem, R.R
 2004
 23 2S p. S112-S113
2 p.
 article
64 Comparison of inflammatory activation and restenosis after percutaneous coronary intervention in heart transplant recipients and patients with stable angina pectoris Hognestad, A
 2004
 23 2S p. S154-S155
2 p.
 article
65 Comparison of left ventricular tissue and right atrial tissue for activation of mitogen-activated protein kinases in canine heart transplantation from non-heart-beating donors Koike, N
 2004
 23 2S p. S152-
1 p.
 article
66 Comparison of novacor and heartmate vented electric left ventricular assist devices in a single institution Kalya, A.V
 2004
 23 2S p. S149-
1 p.
 article
67 Comparison of sirolimus versus azathioprine in a tacrolimus based immunosuppressive regimen in lung transplantation Bhorade, S.M
 2004
 23 2S p. S113-
1 p.
 article
68 Computer simulation predictions of the impact of broader allocation within zone a to status 1a and 1b heart waitlist patients Bustami, R.T
 2004
 23 2S p. S88-
1 p.
 article
69 Congenital category is not a risk factor for pediatric heart transplantation Kanter, K.R
 2004
 23 2S p. S59-
1 p.
 article
70 Conversion to sirolimus lessens renal dysfunction in heart transplant (HTX) patients Hunt, J
 2004
 23 2S p. S113-
1 p.
 article
71 Correlation between TGF-β genotypes and acute and chronic rejection in cardiac transplant recipients Benza, R.L
 2004
 23 2S p. S97-
1 p.
 article
72 C-reactive protein and development of a prothrombogenic microvasculature in heart transplant recipients Labarrere, C.A
 2004
 23 2S p. S123-
1 p.
 article
73 Cyclosporin C2 levels determine rejection rates after lung transplantation Glanville, A.R
 2004
 23 2S p. S113-S114
2 p.
 article
74 Cytokine gene expression profile in myocardial infarction and the cardioprotective effect of des-aspartate-angiotensin-I (DAA-I) Jalil, R.A
 2004
 23 2S p. S101-S102
2 p.
 article
75 Cytolytic induction therapy is a risk factor for bronchiolitis obliterans syndrome after lung transplantation Glanville, A.R
 2004
 23 2S p. S142-
1 p.
 article
76 Cytomegalovirus burden and progressive severity of cardiac allograft vasculopathy Potena, L
 2004
 23 2S p. S164-S165
2 p.
 article
77 Cytomegalovirus (CMV) prophylaxis and infection in pediatric heart transplant recipients Kanter, K.R
 2004
 23 2S p. S126-S127
2 p.
 article
78 Decreased survival in heart transplant patients requiring chronic dialysis: a canadian experience Cantarovich, M
 2004
 23 2S p. S170-S171
2 p.
 article
79 Decrease of waiting list mortality in cardiac transplantation though transplant numbers are dropping. The impact of optimal bridging Mühlbauer, A
 2004
 23 2S p. S130-
1 p.
 article
80 Degree of immunologic injury is the strongest predictor of heart weight increase in the xenotransplantation model Oi, K
 2004
 23 2S p. S86-
1 p.
 article
81 De novo HLA antibodies and lymphocytic bronchiolitis are significantly correlated with bronchiolitis obliterans syndrome in lung transplantation Girnita, A.L
 2004
 23 2S p. S44-
1 p.
 article
82 Detection of vimentin specific autoreactive CD8+T cells in cardiac transplant patients Barber, L.D
 2004
 23 2S p. S122-S123
2 p.
 article
83 Determinants of B-type natriuretic peptide plasma levels in the chronic phase after heart transplantation Klingenberg, R
 2004
 23 2S p. S98-
1 p.
 article
84 Development and validation of a model to predict perioperative mortality following heart transplantation in the UK Ganesh, J.S
 2004
 23 2S p. S118-S119
2 p.
 article
85 Development of panel reactive antibodies following continuous flow micromed-debakey VAD implantation and subsequent effects on allograft rejection Roethy, W.K
 2004
 23 2S p. S109-
1 p.
 article
86 Development of the VAD-QOL: a vad specific quality of life questionnaire Hallas, C.N
 2004
 23 2S p. S135-
1 p.
 article
87 Diagnosis of fungal infections by detection of anti-candida manna antibodies, candida mannan antigen and aspergillus galactomannan antigen in patients following heart and lung transplantation Heizmann, P
 2004
 23 2S p. S90-S91
2 p.
 article
88 Differential gene expression profiling in lung transplant recipients with chronic rejection Lu, B.S
 2004
 23 2S p. S131-
1 p.
 article
89 Difficulty in managing cyclosporin C2 monitoring in de novo lung transplant recipients Cornelissen, J
 2004
 23 2S p. S139-
1 p.
 article
90 Discovery and validation of molecular pathways and diagnostic testing for cardiac rejection in children: a multi-center study Webber, S
 2004
 23 2S p. S167-
1 p.
 article
91 Does donor catecholamine administration affect early lung function post-transplantation? Mukadam, M.E
 2004
 23 2S p. S151-
1 p.
 article
92 Donor cause of death does not affect medium-term survival after heart transplantation - a UK national study Ganesh, J.S
 2004
 23 2S p. S49-
1 p.
 article
93 Donor cause of death does not influence mid-term survival in lung transplant recipients Ganesh, J.S
 2004
 23 2S p. S131-S132
2 p.
 article
94 Donor specific cytotoxic non-responsiveness long after clinical heart transplantation Baan, C.C
 2004
 23 2S p. S46-S47
2 p.
 article
95 Donor-transmitted coronary atherosclerosis and cardiac allograft microvasculopathy Grauhan, O
 2004
 23 2S p. S157-
1 p.
 article
96 Donor tricuspid annuloplasty reduces post-transplant tricuspid regurgitation McGee, E
 2004
 23 2S p. S49-
1 p.
 article
97 Early experience with sirolimus based, calcineurin inhibitor free, immunosuppression for lung transplant recipients Shargall, Y
 2004
 23 2S p. S69-
1 p.
 article
98 Early mechanical restraint improves border zone function during infarction induced ventricular remodeling Pilla, J.J
 2004
 23 2S p. S64-
1 p.
 article
99 Effect of antithymocyte globulin induction, rabbit vs horse, on BOS and survival in lung recipients Valentine, V.G
 2004
 23 2S p. S142-S143
2 p.
 article
100 Effect of mechanical circulatory support on outcomes after heart transplantation in the modern era Drakos, S.G
 2004
 23 2S p. S148-
1 p.
 article
101 Effect of renal replacement therapy on pulmonary mechanics in lung transplantation Valentine, V.G
 2004
 23 2S p. S118-
1 p.
 article
102 Effect on cardioplegic solution with poly(adp-ribose) synthetase (pars) inhibitors, on myocardial ischemia-reperfusion injury in rat hearts Yamazaki, K
 2004
 23 2S p. S151-S152
2 p.
 article
103 Effects of beta-blockers and resynchronization therapy on the performance of the heart failure survival score (HFSS) Distefano, G.D
 2004
 23 2S p. S56-
1 p.
 article
104 Efficacy of thymoglobulin® for the treatment of bos after lung transplantation and predictors of a therapeutic response Hachem, R.R
 2004
 23 2S p. S139-S140
2 p.
 article
105 Elevated IL-15 in acute lung allograft rejection Yu, A.D
 2004
 23 2S p. S165-
1 p.
 article
106 Embryonic stem cell transplantation elicits a primarily Th-1 host T-cell response Kofidis, T
 2004
 23 2S p. S160-S161
2 p.
 article
107 Endothelial dysfunction in cardiac transplant recipients is associated with a vasoconstrictor response to L-NMMA and elevated endothelin levels Kushwaha, S.S
 2004
 23 2S p. S75-
1 p.
 article
108 Epidemiology and clinical implications of atypical mycobacterial infections in cadaveric lung transplants: the role of surveillance bronchoscopy and bronchoalveolar lavage phenotype Hoopes, C
 2004
 23 2S p. S71-S72
2 p.
 article
109 Eras of immunosuppression change risk factors for long-term survival after cardiac transplantation Zuckermann, A
 2004
 23 2S p. S156-S157
2 p.
 article
110 Etiology of low voltage of QRS complex after heart transplantation Cui, G
 2004
 23 2S p. S98-S99
2 p.
 article
111 Evaluation of a fast-track cardiac rehabilitation program after heart transplantation Kaan, A.F
 2004
 23 2S p. S65-
1 p.
 article
112 Exhaled nitric oxide (eNO) correlates with IL-17 in bronchoalveolar lavage fluid (BALF) during acute lung rejection Vanaudenaerde, B.M
 2004
 23 2S p. S166-
1 p.
 article
113 Expanding the donor pool: successful use of marginal donor lungs with a history of smoking Mullen, J.C
 2004
 23 2S p. S130-S131
2 p.
 article
114 Experience with sirolimus in pediatric cardiac transplant recipients Shankel, T.M
 2004
 23 2S p. S77-
1 p.
 article
115 Experimental pulmonary hypertension markedly induces pulmonary artery transient receptor potential protein expression Wolkowicz, P.E
 2004
 23 2S p. S144-
1 p.
 article
116 Ex-vivo and in-vivo effects of GAS 914 on pulmonary xenograft rejection Wiebe, K
 2004
 23 2S p. S86-
1 p.
 article
117 Ex vivo 31P magnetic resonance spectroscopy (MRS) of heart grafts provides metabolic markers of early dysfunction in operating room Caus, T.G
 2004
 23 2S p. S76-
1 p.
 article
118 Ex vivo reperfusion of human lungs declined for transplantation; a novel approach to alleviate donor organ shortage? Neyrinck, A
 2004
 23 2S p. S172-S173
2 p.
 article
119 Favorable effect of Everolimus on cardiac allograft vasculopathy is maintained through 24 months Tuzcu, E.M
 2004
 23 2S p. S51-
1 p.
 article
120 Final results of the study of safety and tolerability of simulect® (basiliximab)versus OKT3 in heart transplantation Rodríguez Lambert, J.L
 2004
 23 2S p. S112-
1 p.
 article
121 First clinical experience with the incor lvad Schmid, C
 2004
 23 2S p. S102-
1 p.
 article
122 First German experience with the cardiowest tah-report from a single center El-Banayosy, A
 2004
 23 2S p. S150-
1 p.
 article
123 Five-year results of a randomized single center study of tacrolimus (TAC) vs. neoral cyclosporine (CYA) Kobashigawa, J.A
 2004
 23 2S p. S46-
1 p.
 article
124 FK 778 directly inhibits adhesion molecule expression after cardiac transplantation: in vivo and in vitro studies Deuse, T
 2004
 23 2S p. S68-
1 p.
 article
125 Frequent surveillance biopsies do not improve survival following heart transplant Wallace, C.K
 2004
 23 2S p. S74-S75
2 p.
 article
126 Function and bulk of respiratory and limb muscles after lung transplantation for cystic fibrosis Estenne, M
 2004
 23 2S p. S96-
1 p.
 article
127 Further analysis of the intravascular ultrasound data from the randomized mycophenolate mofetil (MMF) trial in heart transplant recipients Kobashigawa, J.A
 2004
 23 2S p. S42-
1 p.
 article
128 Galα(1,3)-galactose on xenogeneic endothelium is a putative ligand for human monocytes Peterson, M.D
 2004
 23 2S p. S63-
1 p.
 article
129 Gene expression profiling by multiplex, real time PCR in bronchoscopic biopsies and lavages of allografts in lung transplant recipients Xu, X
 2004
 23 2S p. S81-
1 p.
 article
130 Gene transfer-based blockade of IL-1, IL-17, IL-18, RANTES or MCP-1 cytokine activatory pathways results in prolonged allograft survival in a rat model of heart transplantation Li-Zhong, J
 2004
 23 2S p. S67-
1 p.
 article
131 Graft vasculopathy: comparison of cyclosporine and tacrolimus over 15 + years Baran, D.A
 2004
 23 2S p. S164-
1 p.
 article
132 Has newer therapies improved the survival of cardiac death due to transplant coronary artery disease? Gao, S.-Z
 2004
 23 2S p. S71-
1 p.
 article
133 Health-related quality of life in adolescents after heart transplantation Uzark, K
 2004
 23 2S p. S136-
1 p.
 article
134 Heart-lung transplantation for complex pulmonary atresia: a single centre experience Radley-Smith, R
 2004
 23 2S p. S74-
1 p.
 article
135 Heart transplantation to a physiologic single lung in patients with congenital heart disease Lamour, J.M
 2004
 23 2S p. S58-S59
2 p.
 article
136 Heart transplantation (TX) in baboons from hdaf or GalT-KO pigs Kuwaki, K
 2004
 23 2S p. S87-
1 p.
 article
137 Hemorrhagic shock and resuscitation in organ donors: L-arginine improves impaired lung transplant function Pressler, G
 2004
 23 2S p. S171-
1 p.
 article
138 Heparin induced thrombocytopenia in patients with an axial flow left ventricular assist device Wadia, Y
 2004
 23 2S p. S109-
1 p.
 article
139 High dose rate brachytherapy for in-stent restenosis of lung transplant bronchi Studer, S.M
 2004
 23 2S p. S73-
1 p.
 article
140 Highly efficient reduction of waiting list mortality in lung transplantation Strueber, M
 2004
 23 2S p. S116-
1 p.
 article
141 High-risk coronary interventions involving percutaneous left ventricular support Kar, B
 2004
 23 2S p. S85-S86
2 p.
 article
142 HLA class I & II antibodies post heart transplant are associated with poor allograft outcome Tambur, A.R
 2004
 23 2S p. S60-
1 p.
 article
143 HLA sensitization but not tolerance to incompatible donor ABO antigens follows tissue allograft placement in infant norwood patients Lobach, N.E
 2004
 23 2S p. S166-S167
2 p.
 article
144 Host cells contribute to myocardium early, rather than late, after allogeneic and syngeneic murine heart transplantation Balsam, L.B
 2004
 23 2S p. S133-
1 p.
 article
145 How long does it take to optimise donor haemodynamics? Ozalp, F
 2004
 23 2S p. S87-S88
2 p.
 article
146 Human endothelial T cell costimulation is inhibited by interleukin 10 (IL-10) through induction of suppressor of cytokine secretion-3 (SOCS-3) and ILT-3 Gleissner, C.A
 2004
 23 2S p. S47-S48
2 p.
 article
147 Hypogammaglobulinemia after lung transplantation Shah, L
 2004
 23 2S p. S95-
1 p.
 article
148 Immunisation with vimentin causes rejection of syngeneic cardiac grafts Nair, S
 2004
 23 2S p. S132-S133
2 p.
 article
149 Impact of adequacy of transplant specific education on clinical outcomes after heart transplantation Bordelon, A.J
 2004
 23 2S p. S64-
1 p.
 article
150 Impact of body mass index on survival following heart transplantation Jimenez, J
 2004
 23 2S p. S119-
1 p.
 article
151 Impact of cystic fibrosis-related diabetes (CFRD) on lung transplant outcomes Zamora, M.R
 2004
 23 2S p. S93-
1 p.
 article
152 Impact of diabetes on outcomes after left ventricular assist device placement Butler, J
 2004
 23 2S p. S147-
1 p.
 article
153 Impact of 24 hour continuous hypothermic perfusion on heart preservation by assessment of DNA damage and repair Fitton, T.P
 2004
 23 2S p. S172-
1 p.
 article
154 Impact of late post-transplant acute cardiac rejections on graft function and development of coronary arteriopathy Dandel, M
 2004
 23 2S p. S158-
1 p.
 article
155 Impact of pre-transplant T cell depletion combined with tacrolimus monotherapy on the immune responses in lung transplant recipients Zeevi, A
 2004
 23 2S p. S165-
1 p.
 article
156 Impact of pulmonary artery pressure on survival following lung transplantation for idiopathic pulmonary fibrosis Whelan, T.M
 2004
 23 2S p. S116-S117
2 p.
 article
157 Impact of recipient race, gender, and pregnancy status on mortality following heart transplantation Higgins, R.S.D
 2004
 23 2S p. S169-S170
2 p.
 article
158 Impact of respiratory syncytial virus pneumonia following lung transplantation: a case-controlled study Zamora, M.R
 2004
 23 2S p. S43-S44
2 p.
 article
159 Impact of secondary pulmonary hypertension of lung transplantation outcome Fitton, T
 2004
 23 2S p. S145-S146
2 p.
 article
160 Impact of sirolimus on gonadal function in heart transplant recipients Adamidis, I
 2004
 23 2S p. S140-S141
2 p.
 article
161 Impact of sirolimus on lipid profiles in pediatric thoracic organ recipients Byno, >A
 2004
 23 2S p. S128-
1 p.
 article
162 Impaired coronary flow reserve by contrast-enhanced transthoracic echocardiography predicts cardiac allograft vasculopathy Tona, F
 2004
 23 2S p. S163-S164
2 p.
 article
163 Impair in endothelial-dependent forearm vasodilation in heart transplantation Cuppoletti, A
 2004
 23 2S p. S156-
1 p.
 article
164 Improved heart transplant survival in patients bridged with ventricular assist device Chan, M.C.Y
 2004
 23 2S p. S103-
1 p.
 article
165 Improved viability and reduced apoptosis in subzero 21 hours preservation of transplanted rat hearts using antifreeze proteins Amir, G
 2004
 23 2S p. S171-S172
2 p.
 article
166 Improvement of survival and review of causes of death after heart transplantation: the Stanford experience 1980–1997 Gao, S.-Z
 2004
 23 2S p. S98-
1 p.
 article
167 Incidence and clinical management of life-threatening left ventricular assist device (LVAD) failure Birks, E.J
 2004
 23 2S p. S104-
1 p.
 article
168 Incidence and severity of rejection and infection in patients bridged to transplantation with ventricular assist devices Kaul, P
 2004
 23 2S p. S155-
1 p.
 article
169 Increased gene expression of inflammatory cytokines and endotoxin receptors in peripheral blood mononuclear cells of patients with chronic heart failure Dengler, T.J
 2004
 23 2S p. S173-S174
2 p.
 article
170 Increased incidence of hypertension after orthotopic cardiac transplantation compared with heterotopic cardiac transplantation Taegtmeyer, A.B
 2004
 23 2S p. S92-
1 p.
 article
171 Increasing frequency of adenosine monophosphate deaminase 1 C34T T allele in cardiac donors is associated with reduced pre donation inotrope requirements Taegtmeyer, A.B
 2004
 23 2S p. S89-
1 p.
 article
172 Independent predictors of develop of renal dysfunction after heart transplantation in patients with previously normal renal function Garrido, I.P
 2004
 23 2S p. S170-
1 p.
 article
173 Indirect allorecognition of MHC class I peptides accelerates lung allograft rejection in miniature swine Shoji, T
 2004
 23 2S p. S47-
1 p.
 article
174 Inflammatory parameters as predictors of clinical course in patients with end-stage heart failure Potapov, E.V
 2004
 23 2S p. S82-
1 p.
 article
175 Influence of pre and post-transplant ELISA-detected anti-HLA antibodies on pediatric heart transplant outcome Di Filippo, S
 2004
 23 2S p. S76-S77
2 p.
 article
176 Inhaled nitric oxide as rescue therapy for right ventricular insufficiency after orthotopic heart transplantation Datta, S
 2004
 23 2S p. S158-
1 p.
 article
177 Inhibition of NF-κB by IκB super repressor gene transfer ameliorates ischemia-reperfusion injury after experimental lung transplantation Ishiyama, T
 2004
 23 2S p. S100-
1 p.
 article
178 Inhibition of obliterative airway disease development in murine tracheal allografts by matrix metalloproteinase-9 deficiency Fernandez, F.G
 2004
 23 2S p. S160-
1 p.
 article
179 Inhibition of the receptor kinase activity of vegf and pdgf protects against the development of cardiac allograft arteriosclerosis Nykänen, A.I
 2004
 23 2S p. S124-
1 p.
 article
180 Inhibition of T-lymphocyte stimulation by a trophoblast non-coding RNA suppressing MHC class II expression in murine B-cells Geirsson, A
 2004
 23 2S p. S48-
1 p.
 article
181 Inital experience with oral valgancyclovir for pre-emptive cytomegalovirus therapy after lung transplantation Aigner, C
 2004
 23 2S p. S95-
1 p.
 article
182 Initial benefit of mycophenolate mofetil (MMF) in heart transplant recipients with renal impairment is maintained at two-year follow up Matuszewski, M.J
 2004
 23 2S p. S140-
1 p.
 article
183 INO-1001, a novel poly(ADP-ribose) polymerase inhibitor reduces myocardial and endothelial reperfusion injury after orthotopic heart transplantation Szabo, G
 2004
 23 2S p. S51-
1 p.
 article
184 Insurance with medicare/medicaid is associated with non-adherence in heart failure patients Pamboukian, S.V
 2004
 23 2S p. S83-
1 p.
 article
185 Intracoronary interferon-γ promotes cardiac allograft vasculopathy in miniature swine Hoerbelt, R
 2004
 23 2S p. S124-S125
2 p.
 article
186 Intravascular ultrasound findings 10 years after heart transplantation Segovia, J
 2004
 23 2S p. S72-
1 p.
 article
187 In vitro functional assessment of human skeletal myoblast after transduction with adenoviral bicistronic vector carrying human VEGF165 and ANG-1 Ye, L
 2004
 23 2S p. S102-
1 p.
 article
188 Is oral treatment of CMV-infections with valganciclovir after heart transplantation sufficient? Mueller, M
 2004
 23 2S p. S99-
1 p.
 article
189 Is post heart transplant diastolic dysfunction a risk factor for mortality? Tallaj, J.A
 2004
 23 2S p. S70-
1 p.
 article
190 Lack of porcine endogenous retrovirus (PERV) infection in pig-to-baboon heart xenotrasplantation with persistent depletion of anti-gal antibodies despite the presence of xenoquimerism Domenech, N
 2004
 23 2S p. S63-
1 p.
 article
191 Late acute cardiac rejections in pediatric heart transplantation: incidence and impact on long-term outcome Dandel, M
 2004
 23 2S p. S79-S80
2 p.
 article
192 Late outcomes after heart transplantation in adults with congenital heart disease: a multi-institutional analysis Clemson, B.S
 2004
 23 2S p. S168-S169
2 p.
 article
193 Late survival after heart transplantation: are we getting better at long-term management? Rodeheffer, R.J
 2004
 23 2S p. S163-
1 p.
 article
194 Left ventricular assistance with axial flow pumps: can we control right ventricular function? Kirsch, M.E.W
 2004
 23 2S p. S149-
1 p.
 article
195 Left ventricular assist system: clinical freedom from device replacement Mussivand, T
 2004
 23 2S p. S147-
1 p.
 article
196 Left ventricular recovery following support with left ventricular assist device Colvin-Adams, M.M
 2004
 23 2S p. S105-
1 p.
 article
197 Localized combinatorial IL-4 and IL-10 gene therapy readjusts the balance of endogenous TH1/TH2 cytokines and induces the tolerance of the cardiac allografts Furukawa, H
 2004
 23 2S p. S99-
1 p.
 article
198 Long term outcome after single and bilateral lung transplantation for end-stage pulmonary hypertension de Perrot, M
 2004
 23 2S p. S94-
1 p.
 article
199 Long term outcome of bosentan treatment in primary pulmonary hypertension (PPH) and pulmonary arterial hypertension associated with the scleroderma spectrum of diseases (PAH-SSD) Girgis, R.E
 2004
 23 2S p. S55-
1 p.
 article
200 Long-term preservation using a new apparatus combined with suppression of proinflammatory cytokines improves donor heart function following transplantation in a canine model Oshima, K
 2004
 23 2S p. S151-
1 p.
 article
201 Long-term results of angioplasty versus stenting in cardiac transplant recipients with allograft vasculopathy Simpson, L
 2004
 23 2S p. S154-
1 p.
 article
202 Long-term use of inhaled iloprost in candidates awaiting heart- heart-lung- and lung-transplantation: clinical improvement and reduced pulmonary pressure and resistance Schulz, U
 2004
 23 2S p. S94-
1 p.
 article
203 Low-dose prophylactic intravenous immunoglobulin does not prevent HLA allosensitization in LVAD recipients Drakos, S.G
 2004
 23 2S p. S146-
1 p.
 article
204 Low rate of cardiac recovery despite cellular recovery during LVAD support: results from the LVAD working group Maybaum, S
 2004
 23 2S p. S52-
1 p.
 article
205 Lung transplantation using lungs from donors 50 years of age and older Fischer, S
 2004
 23 2S p. S150-
1 p.
 article
206 Lung transplant with concomitant cardiac surgery: results and long-term survival Parekh, K
 2004
 23 2S p. S74-
1 p.
 article
207 Mechanical unloading leads to echocardiographic, electrophysiological, histological and serological recovery Xydas, S
 2004
 23 2S p. S53-
1 p.
 article
208 Mechanical unloading reverses alterations in cytoskeletal proteins in the failing human heart Aquila-Pastir, L.A
 2004
 23 2S p. S52-
1 p.
 article
209 Melatonin and acute cardiac allograft rejection Jung, F.J
 2004
 23 2S p. S159-S160
2 p.
 article
210 MHC-I expression on donor allogeneic embryonic stem cells transplanted for myocardial repair correlates with indices of differentiation Kofidis, T
 2004
 23 2S p. S101-
1 p.
 article
211 Modified reperfusion in non-standard donor lungs Schnickel, G.T
 2004
 23 2S p. S89-S90
2 p.
 article
212 Molecular testing and prediction of clinical outcome in heart transplantation: a prospective multicenter trial Mehra, M.R
 2004
 23 2S p. S106-
1 p.
 article
213 24-month safety results of a randomized, multicenter, double-blind study of Everolimus vs azathioprine in de novo heart transplant recipients Eisen, H
 2004
 23 2S p. S45-
1 p.
 article
214 Morbidity reduction with the thoratec ventricular assist device (TVAD) for CHF using improved management strategies: a 12 year experience Patel, A.N
 2004
 23 2S p. S148-
1 p.
 article
215 Morphological and molecular effects of clenbuterol on cardiac myocytes - role of IGF-I Barton, P.J.R
 2004
 23 2S p. S53-S54
2 p.
 article
216 MRSA infection is the most important risk factor for the development of bronchial anastomotic complications after lung transplantation Malouf, M.A
 2004
 23 2S p. S132-
1 p.
 article
217 Multi-center intravascular ultrasound validation study among heart transplant recipients: outcomes after 5 years Kobashigawa, J.K
 2004
 23 2S p. S51-
1 p.
 article
218 Multi-frequency forced oscillation technique [FOT] for assessment of lung allograft function: a pilot study Ross, D.J
 2004
 23 2S p. S131-
1 p.
 article
219 Multiple combination bactericidal testing for patients with cystic fibrosis infected with Burkholderia cepacia before and after lung transplantation Scott, A.R
 2004
 23 2S p. S91-
1 p.
 article
220 Mycophenolate mofetil and the risk of developing malignancy following orthotopic heart transplantation O’Neill, J.O
 2004
 23 2S p. S110-
1 p.
 article
221 Myocardial restoration with embryonic stem cell bioartificial tissue transplantation Kofidis, T
 2004
 23 2S p. S161-
1 p.
 article
222 Nebulized N-acetyl cysteine protects the pulmonary graft from the non-heart-beating donor inside the cadaver Rega, F
 2004
 23 2S p. S171-
1 p.
 article
223 Negative association between blood transfusions and acute cardiac allograft rejection Fernandez, F.G
 2004
 23 2S p. S115-
1 p.
 article
224 Nesiritide serial outpatient infusions over 12 weeks show trends towards improved left ventricular systolic function compared to “standard” therapy Saltzberg, M.T
 2004
 23 2S p. S120-
1 p.
 article
225 Neurohumoral and immune markers as predictors of acute deterioration in patients with end stage heart failure requiring ventricular assist device or heart transplantation Potapov, E.V
 2004
 23 2S p. S129-
1 p.
 article
226 New treatments for pulmonary fibrosis: is RAD an answer? Malouf, M.A
 2004
 23 2S p. S175-
1 p.
 article
227 Non-adherence to therapy is a common cause of death in adolescence following heart or lung transplantation Lunnon-Wood, T
 2004
 23 2S p. S77-S78
2 p.
 article
228 Non-alloimmune injury mediated by gastroesophageal reflux precipitates alloimmune injury in lung transplant patients Hartwig, M.G
 2004
 23 2S p. S43-
1 p.
 article
229 Noninvasive identification of cardiac allograft vasculopathy with real-time myocardial contrast echocardiography: comparison with ivus, coronary angiography and 99mTC sestamibi perfusion imaging Stempfle, H.-U
 2004
 23 2S p. S75-S76
2 p.
 article
230 N-terminal brain natriuretic peptide can help to identify patients with a poorer outcome following cardiac transplantation Gardner, R.S
 2004
 23 2S p. S97-S98
2 p.
 article
231 Optimal time point to predict cyclosporine, tacrolimus and mycophenoic acid area-under-the-curve (AUC)0-12 hr in long-term heart/heart-lung transplant patients Cantarovich, M
 2004
 23 2S p. S141-
1 p.
 article
232 Outcome after pre-transplant plasmapheresis for sensitized recipients awaiting heart transplantation Takemoto, S.K
 2004
 23 2S p. S61-
1 p.
 article
233 Outcome of heart-lung and bilateral-sequential single lung transplantation for cystic fibrosis: a UK national study Ganesh, J.S
 2004
 23 2S p. S118-
1 p.
 article
234 Outcome of listing for cardiac transplantation (Tx) for failed fontan: a follow-up multi-institutional study Bernstein, D
 2004
 23 2S p. S162-
1 p.
 article
235 Outcomes of cardiac transplantation with donors 50 years of age and greater Meyer, S.R
 2004
 23 2S p. S169-
1 p.
 article
236 Outpatients on mechanical circulatory support: experience with over 80 patients Drews, T.N.H
 2004
 23 2S p. S108-
1 p.
 article
237 Overexpression of human Bcl-2 attenuates graft coronary artery disease by modulating local th1 immune response but not host immune response in murine cardiac allografts Tanaka, M
 2004
 23 2S p. S161-
1 p.
 article
238 Pai-1 and allograft vasculopathy: insight from a murine model of transplantation Benza, R.L
 2004
 23 2S p. S134-
1 p.
 article
239 Panel-reactive antibody cross-reactivity and outcomes in the pediatric heart transplant study group Mahle, W.T
 2004
 23 2S p. S167-
1 p.
 article
240 Pediatric heart transplantation: quality of life (QOL) outcomes in adolescents Anthony, S.J
 2004
 23 2S p. S137-
1 p.
 article
241 Pediatric lung transplant: do primary pulmonary hypertension patients have worse outcome? Koulouri, S
 2004
 23 2S p. S128-
1 p.
 article
242 Peripheral blood dendritic cell phenotype indicates immune predisposition towards Th-1 responses in human end-stage heart failure Athanassopoulos, P
 2004
 23 2S p. S174-S175
2 p.
 article
243 Peripheral vascular disease adversely affects survival for cardiac transplant recipients Xydas, S
 2004
 23 2S p. S157-S158
2 p.
 article
244 Peroxisome proliferator-activated receptor-γ activation ameliorates acute rejection in rat cardiac allografts Tanaka, Y
 2004
 23 2S p. S67-
1 p.
 article
245 P-glycoprotein and outcome following lung transplantation Fildes, J.E
 2004
 23 2S p. S166-
1 p.
 article
246 Pharmacogenomics in pulmonary arterial hypertension (PAH): the relationship between an ET-1 gene polymorphism (PM) and efficacy of bosentan (BO) Benza, R.L
 2004
 23 2S p. S146-
1 p.
 article
247 Plasmapheresis for humoral rejection and severe graft dysfunction after heart transplantation Ramasubbu, K
 2004
 23 2S p. S70-
1 p.
 article
248 Post-operative atrial dysrhythmias after lung transplantation Lau, C.L
 2004
 23 2S p. S92-
1 p.
 article
249 Post-operative use of aerosolized aztreonam in cystic fibrosis patients colonized with Burkholderia cepacia prior to lung transplantation Woo, M.S
 2004
 23 2S p. S78-
1 p.
 article
250 Postransplant lymphoproliferative disorder (PTLD) may not be associated with development of bronchiolitis obliterans Nador, R.G
 2004
 23 2S p. S155-S156
2 p.
 article
251 P53 plays a significant role in the pathogenesis of allograft vasculopathy Thanikachalam, M.
 2004
 23 2S p. S125-
1 p.
 article
252 Preclinical animal trial and initial clinical experience with the ventrassist-LVAS Esmore, D.S
 2004
 23 2S p. S147-
1 p.
 article
253 Predictive value of the 6-minute walk test in lung transplant outcomes L’Abbe, J
 2004
 23 2S p. S92-S93
2 p.
 article
254 Predictors of physical functional disability at 5–6 years after heart transplantation Grady, K.L
 2004
 23 2S p. S66-
1 p.
 article
255 Predictors of survival in heart failure patients in NYHA class IV Pini, D
 2004
 23 2S p. S58-
1 p.
 article
256 Predictors of survival with a totally implantable left ventricular assist system (LVAS): the european lionheart c linical utility baseline study (CUBS) Pae, W.E
 2004
 23 2S p. S109-
1 p.
 article
257 Preferential depletion of myeloid type peripheral blood dendritic cells during acute rejection of human heart allografts Athanassopoulos, P
 2004
 23 2S p. S114-
1 p.
 article
258 Pre-implantation multiple cytokine mRNA expression analysis in donor lung grafts predicts survival after lung transplantation in humans Kaneda, H
 2004
 23 2S p. S49-S50
2 p.
 article
259 Pre-operative diabetes is associated with reduced survival in the early and chronic phase after heart transplantation Dengler, T.J
 2004
 23 2S p. S75-
1 p.
 article
260 Preoperative screening scale predicts prolonged icu stay after implantation of left ventricular assist devices Morgan, J.A
 2004
 23 2S p. S84-S85
2 p.
 article
261 Preponderance and implications of etiological misclassification in advanced heart failure: a clinical-pathological investigation Uber, P.A
 2004
 23 2S p. S128-S129
2 p.
 article
262 Pre-transplant donor-specific transfusions combined with cyclosporine induce tolerance to MLC class I-mismatched cardiac allografts in miniature swine Hoerbelt, R
 2004
 23 2S p. S48-S49
2 p.
 article
263 Prevention of severe ischemic-reperfusion injury utilizing a multifacated approach during procurement, storage, and reperfusion in lung transplantation Stewart, A
 2004
 23 2S p. S152-S153
2 p.
 article
264 Primary graft failure is associated with increased long-term mortality following lung transplantation independent of development of BOS Christie, J.D
 2004
 23 2S p. S117-
1 p.
 article
265 Primary graft failure (PGF) in cardiac transplantation (OHT) over an 8 year period: the relationship between donor and recipient factors Anagnostopoulos, P
 2004
 23 2S p. S158-
1 p.
 article
266 Procalcitonin and modified sofa score: the best predictors of mortality after heart and lung transplantation Qedra, N
 2004
 23 2S p. S117-
1 p.
 article
267 Prognostication in advanced heart failure with a modified heart failure survival score that takes into account beta-blockers and cardiac resynchronization therapy Distefano, G.D
 2004
 23 2S p. S84-
1 p.
 article
268 Prophylactic sternal plating in the cardiac transplant population Agarwal, J.P
 2004
 23 2S p. S155-
1 p.
 article
269 Prophylactic suture annuloplasty of the tricuspid valve during orthotopic heart transplantation (OHT) - intermediate results of a randomized clinical trial Jeevanandam, V
 2004
 23 2S p. S114-
1 p.
 article
270 Prospective follow-up of panel reactive antibodies in children 5-years following implantation of cryopreserved allografts Hooper, D.K
 2004
 23 2S p. S168-
1 p.
 article
271 Psychosocial determinants and consequences of subclinical non-compliance in lung transplant recipients Cassano-Bailey, A
 2004
 23 2S p. S136-
1 p.
 article
272 Psychosocial variables and quality of life after lung transplantation Kugler, Ch
 2004
 23 2S p. S137-
1 p.
 article
273 Pulmonary capillaritis in lung transplant recipients: response to therapy and effect on long-term allograft function Astor, T.L
 2004
 23 2S p. S166-
1 p.
 article
274 Pulmonary hemodynamics can predict mortality on the waiting list for lung transplantation in patients with cystic fibrosis Venuta, F
 2004
 23 2S p. S145-
1 p.
 article
275 Quality of life after heart transplantation in Japanese patients Shitakura, K
 2004
 23 2S p. S134-S135
2 p.
 article
276 Quantifying health status and functional outcomes following lung transplant L’Abbe, J.M
 2004
 23 2S p. S72-
1 p.
 article
277 Quantifying the resuscitation of hearts procured from nonheartbeating donors with radiolabeled annexin V Prastein, D
 2004
 23 2S p. S153-
1 p.
 article
278 RAD alters the immune response in bronchoalveolar lavage(BAL) and endobronchial biopsy(EBB) post lung transplantation(LTX) Snell, G
 2004
 23 2S p. S69-
1 p.
 article
279 Randomised controlled trial of C0 versus C2 guided therapeutic drug monitoring of cyclosporin-A in stable heart-transplant patients Ozalp, F
 2004
 23 2S p. S107-S108
2 p.
 article
280 Rapamycin conversion for immunosuppressive therapy in the setting of renal insufficiency in patients with heart transplantation: pilot observations Tang, W.H.W
 2004
 23 2S p. S138-
1 p.
 article
281 Rapastat: evaluation of the role of oral sirolimus in the treatment of established graft vessel disease. a prospective, randomized intravascular ultrasound study Segovia, J
 2004
 23 2S p. S51-S52
2 p.
 article
282 Recent trends in biventricular mechanical circulatory support Farrar, D.J
 2004
 23 2S p. S102-S103
2 p.
 article
283 Recipient origin cardiomyocytes in endomyocardial biopsies of human transplanted hearts Angelini, A
 2004
 23 2S p. S123-S124
2 p.
 article
284 Reduced infection with use of left ventricular assist device (LVAD) as an alternative to transplantation Miller, L.W
 2004
 23 2S p. S149-S150
2 p.
 article
285 Refining pathological classification of acute rejection in cardiac allograft recipients: a multicenter study using peripheral blood gene expression profiling Marboe, C.C
 2004
 23 2S p. S42-
1 p.
 article
286 Relation between quality of life and functional variables in lung transplant recipients Sievers, C
 2004
 23 2S p. S65-
1 p.
 article
287 Renal dysfunction is more likely in recipients bridged to heart transplantation with inotropes than with left ventricular assist devices: an analysis of pre-transplant characteristics in the modern era Drakos, S.G
 2004
 23 2S p. S119-
1 p.
 article
288 Renal function is preserved following heart transplantation using IL-2 receptor blockade Wheatley, G
 2004
 23 2S p. S140-
1 p.
 article
289 Renal insufficiency is associated with early mortality in pediatric lung re-transplantation de la Morena, M.T
 2004
 23 2S p. S127-S128
2 p.
 article
290 Renal recovery after conversion to mycophenolate mofetil (MMF) and sirolimus (sir) as calcineurininhibitor-free immunosuppression in late cardiac transplant recipients Groetzner, J
 2004
 23 2S p. S69-
1 p.
 article
291 Results of a tolerance-enhancing protocol in human lung transplantation McCurry, K.R
 2004
 23 2S p. S111-S112
2 p.
 article
292 Results of cardiac transplantation in grown-up patients with congenital heart disease Groetzner, J
 2004
 23 2S p. S80-
1 p.
 article
293 Retransplantation-never too old for one? Patel, J.K
 2004
 23 2S p. S72-
1 p.
 article
294 Retrograde vs. antegrade lung flush perfusion for graft preservation in clinical lung transplantation Gohrbandt, B
 2004
 23 2S p. S89-
1 p.
 article
295 Right ventricular stroke work index (RVSWI) predicts duration of inotropic support after left ventricular assist device implantation Schenk, S
 2004
 23 2S p. S108-
1 p.
 article
296 Risk/benefit evaluation of tacrolimus (TAC) vs. cyclosporine microemulsion (CsA) after cardiac transplantation: 18-month results Rinaldi, M
 2004
 23 2S p. S45-S46
2 p.
 article
297 Risk factors for acute rejection and vasculopathy among 634 patients treated with everolimus or azathioprine Starling, R.C
 2004
 23 2S p. S138-S139
2 p.
 article
298 Role of flow cytometry to exclude unacceptable HLA antigens in lung transplant recipients with anti-HLA antibodies Appel, J.Z
 2004
 23 2S p. S44-
1 p.
 article
299 Role of left ventrcular assist device for patients in acute myocardial infarction complicated by cardiogenic shock Park, S.J
 2004
 23 2S p. S130-
1 p.
 article
300 Role of open lung biopsy for diagnosis in pediatric lung transplant recipients: a twelve-year experience Choong, C.K
 2004
 23 2S p. S60-
1 p.
 article
301 Role of voriconazole prophylaxis for the prevention of invasive aspergillosis (IA) at six months in lung transplant recipients Husain, S
 2004
 23 2S p. S110-
1 p.
 article
302 Routine angiography post cardiac transplantation: what value? Rockx, M.A.J
 2004
 23 2S p. S71-
1 p.
 article
303 Safety and efficacy of rosuvastatin therapy for the prevention of hyperlipidemia in adult cardiac transplant recipients Samman, A.M
 2004
 23 2S p. S91-S92
2 p.
 article
304 Selective upregulation of the beta1-adrenergic receptor, dephosphorylation of cardiac troponin I and influence of beta-blocker therapy in patients suffering from terminal heart failure and supported by ventricular assist devices Milting, H
 2004
 23 2S p. S53-
1 p.
 article
305 Short and long term LVAD use decreases pulmonary vascular resistance Dyke, D.B
 2004
 23 2S p. S103-
1 p.
 article
306 Should MADIT-II criteria apply to patients treated in a heart failure specialty clinic? Montpetit, M.C
 2004
 23 2S p. S82-
1 p.
 article
307 Significance of persistent post-transplant antibody after cardiac transplantation Takemoto, S.K
 2004
 23 2S p. S60-S61
2 p.
 article
308 Sildenafil is effective and safe in reversing pulmonary hypertension in advanced heart failure Alaeddini, J
 2004
 23 2S p. S119-S120
2 p.
 article
309 Silent & symptomatic gastro-oesophageal reflux (GOR) in cystic fibrosis (CF) pre & post lung transplantation- are they a problem? Button, B
 2004
 23 2S p. S144-S145
2 p.
 article
310 Simvastatin decreases myocardial tumor necrosis factor-α content in heart transplant recipients Wallace, C.K
 2004
 23 2S p. S114-S115
2 p.
 article
311 Single centre prognostic modelling of cystic fibrosis patients referred for lung transplantation De Soyza, A
 2004
 23 2S p. S93-
1 p.
 article
312 Sirolimus from the time of heart transplantation - persistent protection from graft vasculopathy at 2 years Keogh, A
 2004
 23 2S p. S106-S107
2 p.
 article
313 Sirolimus immunosuppression in paediatric heart transplant patients: a single centre experience Lobach, N.E
 2004
 23 2S p. S167-S168
2 p.
 article
314 Sirolimus in combination with Tacrolimus for primary immunosuppression after heart transplantation Mueller, M
 2004
 23 2S p. S46-
1 p.
 article
315 Sirolimus(SRL) in heart transplantation: preliminary results of a multicenter registry in Spain Crespo, M.G
 2004
 23 2S p. S141-
1 p.
 article
316 Six month data of a 12-month, single-blind, randomized, parallel group, multicenter study to investigate the efficacy and safety of enteric-coated mycophenolate sodium (EC-MPS, myfortic®) compared with mycophenolate mofetil (MMF) in de novo heart transplant recipients Kobashigawa, J.A
 2004
 23 2S p. S44-S45
2 p.
 article
317 Skin diseases after lung transplantation Eich, Ch
 2004
 23 2S p. S145-
1 p.
 article
318 S-nitroso-human serum albumin improves organ preservation in orthotopic heart transplantation in the pig Gottardi, R
 2004
 23 2S p. S172-
1 p.
 article
319 Soluble CD40 ligand in pulmonary arterial hypertension - possible pathogenic role of interaction between platelets and endothelial cells Damas, J.K
 2004
 23 2S p. S54-
1 p.
 article
320 STAT-1 and AP-1 decoy-oligodeoxynucleotode therapy delays acute rejection and prolongs cardiac allograft survival Stadlbauer, T.H.W
 2004
 23 2S p. S159-
1 p.
 article
321 Stimulation of paracrine pathways enhances embryonic stem cell engraftment and differentiation in the injured heart de Bruin, J.L
 2004
 23 2S p. S101-
1 p.
 article
322 Striving for normalcy: symptoms and the threat of rejection after lung transplant DeVito Dabbs, A.J
 2004
 23 2S p. S66-
1 p.
 article
323 Successful transplantation of B. cepacia complex infected cystic fibrosis patients; transplanting B. cenocepacia (genomovar III) infected patients De Soyza, A
 2004
 23 2S p. S73-S74
2 p.
 article
324 Successful treatment of relapsed PTLD with YT-90/anti-CD20 radioimmunotherapy Patel, A.C
 2004
 23 2S p. S91-
1 p.
 article
325 Successful treatment of vascular rejection with rituximab in cardiac transplants Garrett Jr, H.E
 2004
 23 2S p. S70-
1 p.
 article
326 Sudden death in patients evaluated for heart transplantation: HFSS detects possible candidates for prophylactic ICD implantation Naegele, H
 2004
 23 2S p. S57-
1 p.
 article
327 Surgical treatment for congestive heart failure using autologous adult stem cell transplantation: early results Patel, A.N
 2004
 23 2S p. S62-S63
2 p.
 article
328 Survival following lung transplantation (LT) of cystic fibrosis (CF) patients infected with burkholderia cepacia complex (BCC) Alexander, B.D
 2004
 23 2S p. S73-
1 p.
 article
329 Sustained long term improvement after transition from I.V. epoprostenol to S.C. treprostinil therapy in patients with pulmonary arterial hypertension Vachiery, J.-L
 2004
 23 2S p. S144-
1 p.
 article
330 Sustained reversal of electrical remodeling during and after left ventricular assist device (LVAD) support Hardy, J
 2004
 23 2S p. S52-S53
2 p.
 article
331 Systemic neutrophil activation and lung injury in the brain-dead donor is a biphasic phenomenon Avlonitis, V.S
 2004
 23 2S p. S88-
1 p.
 article
332 Targeting STAT-1 AND AP-1 transcription factors by decoy-oligodeoxynucleotides prevents graft vasculopathy in a chronic rat cardiac transplantation model Stadlbauer, T.H.W
 2004
 23 2S p. S125-
1 p.
 article
333 Ten year follow-up of the functional and morphological adaptation of undersized donor hearts following cardiac transplantation Mather, P.J
 2004
 23 2S p. S169-
1 p.
 article
334 Ten year survival after paediatric heart transplantation: a single centre experience Radley-Smith, R
 2004
 23 2S p. S79-
1 p.
 article
335 Tetrahydrobiopterin prevents cyclosporine induced vasomotor dysfunction of the rat thoracic aorta Ramzy, D
 2004
 23 2S p. S67-
1 p.
 article
336 TGFβ1 polymorphisms and transplant coronary artery disease Miriuka, S.G
 2004
 23 2S p. S156-
1 p.
 article
337 The angiotensin converting enzyme insertion deletion polymorphism does not influence the development or progression of post-cardiac transplant hypertension Fildes, J.E
 2004
 23 2S p. S90-
1 p.
 article
338 The effect of CSA, FK506 and MMF on the expression of inducible cell adhesion molecules (iCAMs), transplant vasculopathy and leukocyte infiltration Richter, M.H.C
 2004
 23 2S p. S68-
1 p.
 article
339 The effect of etanercept on cardiac transplants Torre-Amione, G
 2004
 23 2S p. S107-
1 p.
 article
340 The effect of immunosuppression on bone marrow-derived recipient cells in murine cardiac allografts Rezai, N
 2004
 23 2S p. S124-
1 p.
 article
341 The effects of levosimendan in refractory congestive heart failure needing IV inotropic drugs:a logistic regression analysis of the believe study comparing responders versus non responders Bocchi, E.A
 2004
 23 2S p. S129-S130
2 p.
 article
342 The efficacy of cardiomyocyte transplantation is enhanced by epicardial application of control-released hepatocyte growth factor in infarcted hearts Tambara, K
 2004
 23 2S p. S99-
1 p.
 article
343 The highly sensitized patient awaiting heart transplantation: success with combination therapy of plasmapheresis and intravenous gamma globulin Kobashigawa, J.A
 2004
 23 2S p. S61-
1 p.
 article
344 The ICU O2 challenge should not be used for donor lung function decision making McGiffin, D.C
 2004
 23 2S p. S50-
1 p.
 article
345 The impact of cytogam on cardiac transplant recipients with moderate hypogammaglobulinemia Yamani, M.H
 2004
 23 2S p. S157-
1 p.
 article
346 The impact of pretransplant diagnosis and surgical palliation on the long-term outcome of pediatric cardiac transplantation Eckermann, J.M
 2004
 23 2S p. S58-
1 p.
 article
347 The impact of transplantation on the cognitive development and behaviour of children Wray, J
 2004
 23 2S p. S65-
1 p.
 article
348 The interaction of underlying etiology of pulmonary hypertension and response to bosentan Park, M.H
 2004
 23 2S p. S143-S144
2 p.
 article
349 The lazarus syndrome and the cult of the superman Glanville, A.R
 2004
 23 2S p. S121-
1 p.
 article
350 The munich score-a clinical index to predict survival in patients with chronic heart failure in the era of new medical therapies Stempfle, H.-U
 2004
 23 2S p. S129-
1 p.
 article
351 The presence of non-HLA IgM antibody adversely effects graft survival following both heart and lung transplantation Stanford, R.E
 2004
 23 2S p. S162-
1 p.
 article
352 The profibrotic cytokine transforming growth factor beta (TGFβ) is elevated early in the development of bronchiolitis obliterans syndrome (BOS) in lung transplant recipients (LTR) McWilliams, T.J
 2004
 23 2S p. S126-
1 p.
 article
353 The prospective use of plasmapheresis and IVIG in sensitized patients prior to heart transplantation Weston, M.W
 2004
 23 2S p. S61-S62
2 p.
 article
354 Therapeutic drug monotoring of everolimus (RAD) may be beneficial in stable lung transplant recipients Pirron, U
 2004
 23 2S p. S142-
1 p.
 article
355 Therapy to prevent osteoporosis may be discontinued one year after heart transplantation in patients with normal bone density Addesso, V
 2004
 23 2S p. S111-
1 p.
 article
356 The relationship between self perception and adherence in adolescents and young adults Wray, J
 2004
 23 2S p. S136-S137
2 p.
 article
357 The relative importance of the direct and indirect allogeneic presentation pathways during early and late clinical cardiac rejection van Besouw, N.M
 2004
 23 2S p. S100-
1 p.
 article
358 The relevance of HLA antibody and a donor specific flow cytometry crossmatch to rejection and graft survival in cardiac allograft recipients Przybylowski, P
 2004
 23 2S p. S62-
1 p.
 article
359 The role of hypogonadism on bone loss after cardiac transplantation: is a testosterone replacement therapy necessary? Stempfle, H.-U
 2004
 23 2S p. S111-
1 p.
 article
360 The role of nitric oxide in cardiomyogenesis using embryonic stem cells Shears, L.L
 2004
 23 2S p. S173-
1 p.
 article
361 The role of p38 in obliterative airway disease in rats Farivar, A.S
 2004
 23 2S p. S100-
1 p.
 article
362 The role of self-expandable metallic stents (SEMS) in promoting healing of post lung transplant bronchial dehiscence Mughal, M.M
 2004
 23 2S p. S153-S154
2 p.
 article
363 The significance of a low initial hematocrit value as a prognostic factor in patients with severe heart failure Terrovitis, J
 2004
 23 2S p. S82-S83
2 p.
 article
364 The success of the urgent heart offering schemes in the UK Seeney, F.M
 2004
 23 2S p. S115-S116
2 p.
 article
365 The TGF-β signalling pathway is activated in coronary artery vasculopathy Atkinson, C
 2004
 23 2S p. S80-
1 p.
 article
366 The thoratec IVAD: a new implantable ventricular assist device Slaughter, M.S
 2004
 23 2S p. S149-
1 p.
 article
367 The use of thiazolidinedione agents in post cardiac transplant diabetic patients Srikanthan, P
 2004
 23 2S p. S90-
1 p.
 article
368 The utility of b-type natriuretic peptide levels in demarcating the distinct hemodynamic profiles of chronic heart failure Alaswad, K
 2004
 23 2S p. S81-S82
2 p.
 article
369 The value of B-type natriuretic peptide in predicting allograft rejection in cardiac transplant recipients Bader, F.M
 2004
 23 2S p. S97-
1 p.
 article
370 Tissue implantation with autologous myoblast sheet improved cardiac performance in the impaired myocardium Sawa, Y
 2004
 23 2S p. S159-
1 p.
 article
371 TNF inhibition at the time of myocardial infarction attenuates the subsequent development of heart failure Berry, M.F
 2004
 23 2S p. S174-
1 p.
 article
372 Total artificial heart cardiowest in small patients Leprince, P
 2004
 23 2S p. S105-S106
2 p.
 article
373 TRACLEER® (bosentan), for the treatment of pulmonary arterial hypertension (PAH) - 6 month quality of life data Keogh, A
 2004
 23 2S p. S54-
1 p.
 article
374 Transcutaneous electrical nerve stimulation for severe gastroparesis after lung transplantation Weinkauf, J.G
 2004
 23 2S p. S153-
1 p.
 article
375 Transplant rejection: vertebrate animals’ programmed maintenance of internal dynamic molecular architecture Pajaro, O.E
 2004
 23 2S p. S121-S122
2 p.
 article
376 Two-year follow-up of psychological state in patients referred for heart transplant Evangelista, L.S
 2004
 23 2S p. S135-S136
2 p.
 article
377 Two year pre-emptive approach of post transplant lymphoproliferative disease after lung transplantation Verschuuren, E.A.M
 2004
 23 2S p. S110-
1 p.
 article
378 Two-year results of an international, randomized, double-blind study of everolimus (RAD) vs azathioprine to inhibit the decline of pulmonary function in stable lung transplant recipients Snell, G.I
 2004
 23 2S p. S45-
1 p.
 article
379 Unilateral acute and chronic rejection after living-donor lobar lung transplantation Date, H
 2004
 23 2S p. S143-
1 p.
 article
380 Upgrade from standard right sided pacing to cardiac resynchronization therapy shows clinical benefit as in denovo implantation Pamboukian, S.V
 2004
 23 2S p. S84-
1 p.
 article
381 Upregulation of IL-17 in acute rejection after lung transplantation Dupont, L.J
 2004
 23 2S p. S165-
1 p.
 article
382 Use of marginal donor hearts in paediatric heart recipients Neligan, S
 2004
 23 2S p. S50-
1 p.
 article
383 Utility of iodine-123 metaiodobenzylguanidine scintigraphy on candidate selection for heart transplantation Yazaki, Y
 2004
 23 2S p. S56-S57
2 p.
 article
384 Utility of serial panel reactive antibody determinations following pediatric heart transplant Lamour, J.M
 2004
 23 2S p. S78-S79
2 p.
 article
385 Value of early creatinine clearance to predict late renal function in pediatric heart transplant patients Di Filippo, S
 2004
 23 2S p. S79-
1 p.
 article
386 Value of non invasive tissue doppler derived Tei-index in detection of transplant vasculopathy in pediatric heart transplant recipients Abdul-Khaliq, H
 2004
 23 2S p. S168-
1 p.
 article
387 Vascular endothelial growth factor gene polymorphism are associated with allograft coronary artery disease after clinical heart transplantation Datta, S
 2004
 23 2S p. S160-
1 p.
 article
388 VEGF-C induces collateral formation in ischaemic porcine heart model Pätilä, T.I
 2004
 23 2S p. S85-
1 p.
 article
389 Ventilatory efficiency is improved in cardiac transplant recipients following 12 weeks of combined aerobic and strength training Eves, N.D
 2004
 23 2S p. S96-
1 p.
 article
390 Waiting list survival and cardiac transplant outcome of patients supported on left ventricular assist device vs. inotropic support: comparison of two eras Zuckermann, A
 2004
 23 2S p. S120-
1 p.
 article
391 Why left ventricular assist devices are not yet a product that has matured to the tornado phase of the market: or why aren’t we using more LVAD’S? Kormos, R.L
 2004
 23 2S p. S122-
1 p.
 article
392 Will device change-out be inevitable in destination therapy? Park, S.J
 2004
 23 2S p. S63-S64
2 p.
 article
393 Xenotransplantation: a new darwinian vantage? Khalpey, Z.I
 2004
 23 2S p. S121-
1 p.
 article
394 10-year results of the pravastatin randomized trial in heart transplant recipients Kobashigawa, J.A
 2004
 23 2S p. S115-
1 p.
 article
                             394 results found
 
 Koninklijke Bibliotheek - National Library of the Netherlands